Marsha Wittink, M.D., studies how to empower older patients. Learn more Rudi Fasan, Ph.D., Ben Frisch, Ph.D., and Danielle Benoit, Ph.D. are collaborating to develop a new leukemia drug and a new way of delivering it with nanoparticles. Learn more Laura Calvi, M.D. and Jacky Williams, Ph.D., are studying the tumor microenvironment using a new high-technology device that will allow them to look more deeply into connections between cancer cells and surrounding tissues. Learn more Melvin King, research assistant, works with Brad Smith, Ph.D., and Josh Munger, Ph.D., who are collaborating to study how cancer cells reproduce. Learn more
Research Programs Wilmot scientists are supported by grants from a variety of sources, including the National Cancer Institute, several nationally respected cancer foundations, and industry groups. Learn More
Research Faculty & Staff The Wilmot Cancer Institute has a large, dedicated group of scientists from 30 academic departments at the University of Rochester and the Wilmot Cancer Institute. Learn More
Clinical Trials Clinical trials are the backbone of cancer research, identifying better and safer treatments for patients. If you volunteer to enroll in a trial, you are helping to improve cancer care. Learn More
Research News CLL Wonder Drug has a Downside: Weight GainCardiac Resynchronization Therapy Benefits Cancer Survivors with Heart FailureTailor-made for Older Adults, New Tools Improve Oncologist-Patient RelationsNIH Grant Funds Fitness App for Geriatric OncologyWhat Brings Cancer Patients to the Emergency Room? Researchers Find Answers, Suggest Changes
Research Programs The Wilmot Cancer Institute has a large, dedicated group of scientists from 30 academic departments at the University of Rochester and the Wilmot Cancer Institute. Thanks to ongoing basic and clinical research by our teams, patients throughout upstate New York continuously gain new survival advantages. Hallmarks of Cancer Tumor Microenvironment Cancer Control & Survivorship